How does vatiquinone help with FA?
Category:
Vatiquinone
Vatiquinone is an experimental therapy that’s not yet approved for treating Friedreich’s ataxia (FA). It’s designed to limit neuroinflammation and nerve cell damage in people with FA by blocking the activity of an enzyme called 15-lipoxygenase. In clinical trials, this has led to significant reductions in disease progression.